Fever After Peripheral Blood Stem Cell Infusion in Haploidentical Transplantation with Post-transplant Cyclophosphamide
Conclusion Fever after peripheral blood stem cell infusion in this clinical setting was common; it usually subsides with cyclophosphamide administration. The development of fever was not associated with an adverse prognosis.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Hematology | Intensive Care | Respiratory Medicine | Stem Cell Therapy | Stem Cells | Study | Transplants